Clinical Trial Update: Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating panitumumab with gemcitabine and carboplatin in metastatic triple-negative breast cancer; the study has been completed and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Panitumumab (panitumumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-12-15